An institutional holder
Filed with the SEC on · accession 0000919574-26-005526
CNTA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Centessa Pharmaceuticals plc.
An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Centessa Pharmaceuticals plc. The filing indicates a change in the holder's ownership stake.
✦ Ask GOAX AI about this filing — what it means for CNTA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CNTA?
Click hereCNTA filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Centessa Pharmaceuticals plc. The filing indicates a change in the holder's ownership stake.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Get alerts when CNTA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days